Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.19.1
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 29,448 $ 2,671
Deferred financing costs 61 1,702
Prepaid expenses and other current assets 254 152
Total Assets 29,763 4,525
Current Liabilities:    
Accounts payable and accrued expenses 9,326 4,669
Accounts payable and accrued expenses - related party 86 487
Total current liabilities 9,412 5,156
Total Liabilities 9,412 5,156
Commitments and Contingencies
Stockholders' Equity (Deficit)    
Common Stock ($0.0001 par value), 50,000,000 shares authorized Common shares; 16,557,122 and 10,667,714 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively 2 1
Additional paid-in capital 73,827 41,577
Accumulated deficit (53,478) (42,209)
Total Stockholders' Equity (Deficit) 20,351 (631)
Total Liabilities and Stockholders' Equity (Deficit) 29,763 4,525
Series A Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred Stock ($0.0001 par value), 2,000,000 shares authorized Class A Preferred Stock, 250,000 shares issued and outstanding as of March 31, 2019 and December 31, 2018 $ 0 $ 0